Rafael Amado
Director/Board Member bei POSEIDA THERAPEUTICS, INC.
Vermögen: 508 947 $ am 31.03.2024
Profil
Zurzeit bekleidet Rafael G. Amado die Position des Chief Medical Officer, EVP-Research & Development bei Allogene Therapeutics, Inc. In der Vergangenheit war er President-Research & Development bei Adaptimmune Therapeutics Plc, Senior Vice President bei GlaxoSmithKline Plc, Executive Director-Therapeutic Oncology bei Amgen Ltd. und Assistant Clinical Professor an der University of California, Los Angeles. Rafael G. Amado promovierte an der Universität von Sevilla.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2023 | 77 135 ( 0,05% ) | 344 793 $ | 31.03.2024 | |
| 01.05.2023 | 39 300 ( 0,04% ) | 125 367 $ | 31.03.2024 | |
ZAI LAB LTD.
0,00% | 04.04.2024 | 23 532 ( 0,00% ) | 38 787 $ | 31.03.2024 |
Aktive Positionen von Rafael Amado
| Unternehmen | Position | Beginn |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Director/Board Member | 13.04.2023 |
Ehemalige bekannte Positionen von Rafael Amado
| Unternehmen | Position | Ende |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30.12.2022 |
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 12.08.2019 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01.07.2019 |
| GSK PLC | Corporate Officer/Principal | 01.03.2015 |
Amgen Ltd.
 Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01.08.2008 |
Ausbildung von Rafael Amado
| University of Seville | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| GSK PLC | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Amgen Ltd.
Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Health Services |
